Samsung Biologics Co vs Vertex Pharmaceuticals: Fair Value & Quality
Both stocks run through our valuation models. Here is how Samsung Biologics Co (207940) and Vertex Pharmaceuticals (VRTX) compare, as of Sep 5, 2026.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Samsung Biologics Co leads: 6 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | Samsung Biologics CoPrice KRW 1,447,000 | Vertex PharmaceuticalsPrice $558 |
|---|---|---|
| DCF Models | ▼-37%below the priceKRW 912,339 | ▼-19%below the price$453 |
| Earnings-Based | ●-7%close to the priceKRW 1,349,126 | ●-8%close to the price$516 |
| Dividend Discount | n/a | ▼-99%below the price$7.07 |
| Multiples | ▼-51%below the priceKRW 702,735 | ▼-50%below the price$278 |
| Asset-Based | ▼-93%below the priceKRW 107,845 | ▼-91%below the price$49.27 |
| Growth DCF | ▼-63%below the priceKRW 533,553 | ▼-38%below the price$348 |
| Economic Profit | ▼-54%below the priceKRW 660,555 | ▼-54%below the price$254 |
| Growth Earnings | ▲+24%above the priceKRW 1,790,868 | ▲+24%above the price$692 |
| Minimum | ▼-93%below the priceKRW 107,845 | ▼-99%below the price$7.07 |
| Maximum | ▲+24%above the priceKRW 1,790,868 | ▲+24%above the price$692 |
| Median | ▼-51%below the priceKRW 702,735 | ▼-44%below the price$313 |
| Geometric mean | ▼-54%below the priceKRW 667,235 | ▼-67%below the price$185 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
Samsung Biologics Co: 22 of 24 models see the stock below the current price.
Vertex Pharmaceuticals: 22 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Samsung Biologics Co · Health Care
Vertex Pharmaceuticals · Health Care
Bottom line
As of Sep 5, 2026, Fair Value Calculator sees Samsung Biologics Co as the less overvalued of the two: Samsung Biologics Co trades at KRW 1,447,000 versus a fair value of KRW 1,055,793 (-27%), while Vertex Pharmaceuticals trades at $558 versus $279 (-50%).
Samsung Biologics Co has the higher quality score (82/100).
See the full analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.